Lung Cancer Screening Market Size & Opportunities Analysis - Growth Strategies, Competitiveness, and Forecasts (2026

Description

The lung cancer screening market is witnessing steady growth as healthcare systems worldwide intensify efforts to detect lung cancer at earlier and more treatable stages. The market is valued at USD 3.6 billion in 2025 and is projected to reach USD 6.5 billion by 2032, growing at a CAGR of 8.8% during the study period from 2019 to 2032. Rising incidence of lung cancer, increasing awareness of early diagnosis benefits, and expanding screening programs are supporting sustained market expansion.

Advancements in imaging technologies and growing adoption of low-dose computed tomography are improving screening accuracy and patient outcomes. Governments and healthcare organizations are promoting population-based screening initiatives, particularly for high-risk groups such as smokers and individuals with prolonged exposure to environmental risk factors. These efforts are strengthening demand for lung cancer screening services and diagnostic solutions.

North America represents the largest regional market, supported by established screening guidelines, advanced healthcare infrastructure, and strong reimbursement frameworks, while the Asia-Pacific region is emerging as the fastest-growing market due to rising disease burden, improving access to diagnostic services, and increasing healthcare investment. As early detection continues to gain importance, the lung cancer screening market is expected to maintain consistent growth throughout the forecast period.

Key Insights

The lung cancer screening market is valued at USD 3.6 billion in 2025 and is expected to reach USD 6.5 billion by 2032, reflecting steady long-term growth driven by increasing emphasis on early cancer detection.

The market is projected to grow at a CAGR of 8.8% during 2019-2032, supported by expanding screening programs and technological advancements in diagnostic imaging.

Growing awareness of the clinical and economic benefits of early lung cancer diagnosis is strengthening demand for screening services globally.

North America accounts for the largest share of the global market, driven by strong screening adoption, favorable reimbursement policies, and advanced diagnostic infrastructure.

The Asia-Pacific region is the fastest-growing market, supported by rising lung cancer incidence, improving healthcare access, and expanding public health initiatives.

Increasing adoption of low-dose CT screening is improving detection rates and reducing mortality associated with lung cancer.

Government-backed screening initiatives and preventive healthcare programs are accelerating market growth across multiple regions.

Technological advancements in imaging systems and data analytics are enhancing screening accuracy and workflow efficiency.

Growing focus on preventive healthcare and early intervention is encouraging healthcare providers to expand screening capabilities.

Continuous investment in diagnostic infrastructure, awareness campaigns, and screening technologies is expected to sustain long-term growth in the lung cancer screening market.

Product Code: 13821

Chapter 1. Research Scope

1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
- 1.4.1. Market Size Breakdown, by Cancer Type
- 1.4.2. Market Size Breakdown, by Technology
- 1.4.3. Market Size Breakdown, by Sample Type
- 1.4.4. Market Size Breakdown, by Age Group
- 1.4.5. Market Size Breakdown, by Patient Type
- 1.4.6. Market Size Breakdown, by End User
- 1.4.7. Market Size Breakdown, by Region
- 1.4.8. Market Size Breakdown, by Country
1.5. Market Data Reporting Unit
- 1.5.1. Revenue
1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence Database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Industry Background
5.2. Market Dynamics
- 5.2.1. Trends
- 5.2.2. Drivers
- 5.2.3. Restraints/Challenges
- 5.2.4. Emerging Economies and Key Opportunities
- 5.2.5. Impact Analysis of Drivers/Restraints
5.3. Sociopolitical Impact
5.4. Porter's Five Forces Analysis
- 5.4.1. Bargaining Power of Buyers
- 5.4.2. Bargaining Power of Suppliers
- 5.4.3. Threat of New Entrants
- 5.4.4. Intensity of Rivalry
- 5.4.5. Threat of Substitutes
5.5. Lifecycle Analysis
5.6. Innovation and Technology Trends
5.7. Economic and Regulatory Impact
5.8. Market Entry Strategies

Chapter 6. Competitive Landscape

6.1. List of Market Players and their Offerings
6.2. Market Share of Key Players (2025)
- 6.2.1. Global
- 6.2.2. North America
- 6.2.3. Europe
- 6.2.4. Asia-Pacific
- 6.2.5. Latin America
- 6.2.6. Middle East and Africa
6.3. Competitive Benchmarking of Key Players
6.4. Product Benchmarking of Key Players
6.5. Recent Strategic Developments by Key Players
6.6. Company Leadership Matrix

Chapter 7. Global Market

7.1. Overview
7.2. Market Revenue, by Cancer Type (2019-2032)
7.3. Market Revenue, by Technology (2019-2032)
7.4. Market Revenue, by Sample Type (2019-2032)
7.5. Market Revenue, by Age Group (2019-2032)
7.6. Market Revenue, by Patient Type (2019-2032)
7.7. Market Revenue, by End User (2019-2032)
7.8. Market Revenue, by Region (2019-2032)

Chapter 8. North America Market

8.1. Overview
8.2. Market Revenue, by Cancer Type (2019-2032)
8.3. Market Revenue, by Technology (2019-2032)
8.4. Market Revenue, by Sample Type (2019-2032)
8.5. Market Revenue, by Age Group (2019-2032)
8.6. Market Revenue, by Patient Type (2019-2032)
8.7. Market Revenue, by End User (2019-2032)
8.8. Market Revenue, by Country (2019-2032)

Chapter 9. Europe Market

9.1. Overview
9.2. Market Revenue, by Cancer Type (2019-2032)
9.3. Market Revenue, by Technology (2019-2032)
9.4. Market Revenue, by Sample Type (2019-2032)
9.5. Market Revenue, by Age Group (2019-2032)
9.6. Market Revenue, by Patient Type (2019-2032)
9.7. Market Revenue, by End User (2019-2032)
9.8. Market Revenue, by Country (2019-2032)

Chapter 10. Asia-Pacific Market

10.1. Overview
10.2. Market Revenue, by Cancer Type (2019-2032)
10.3. Market Revenue, by Technology (2019-2032)
10.4. Market Revenue, by Sample Type (2019-2032)
10.5. Market Revenue, by Age Group (2019-2032)
10.6. Market Revenue, by Patient Type (2019-2032)
10.7. Market Revenue, by End User (2019-2032)
10.8. Market Revenue, by Country (2019-2032)

Chapter 11. Latin America Market

11.1. Overview
11.2. Market Revenue, by Cancer Type (2019-2032)
11.3. Market Revenue, by Technology (2019-2032)
11.4. Market Revenue, by Sample Type (2019-2032)
11.5. Market Revenue, by Age Group (2019-2032)
11.6. Market Revenue, by Patient Type (2019-2032)
11.7. Market Revenue, by End User (2019-2032)
11.8. Market Revenue, by Country (2019-2032)

Chapter 12. Middle East and Africa Market

12.1. Overview
12.2. Market Revenue, by Cancer Type (2019-2032)
12.3. Market Revenue, by Technology (2019-2032)
12.4. Market Revenue, by Sample Type (2019-2032)
12.5. Market Revenue, by Age Group (2019-2032)
12.6. Market Revenue, by Patient Type (2019-2032)
12.7. Market Revenue, by End User (2019-2032)
12.8. Market Revenue, by Country (2019-2032)

Chapter 13. U.S. Market

13.1. Overview
13.2. Economic Indicators
13.3. Demographics and Population Insights
13.4. Growth Drivers
13.5. Challenges and Barriers
13.6. Competitive Strategies
13.7. Emerging Players
13.8. Market Size and Forecast
- 13.8.1. Market Revenue, by Cancer Type (2019-2032)
- 13.8.2. Market Revenue, by Technology (2019-2032)
- 13.8.3. Market Revenue, by Sample Type (2019-2032)
- 13.8.4. Market Revenue, by Age Group (2019-2032)
- 13.8.5. Market Revenue, by Patient Type (2019-2032)
- 13.8.6. Market Revenue, by End User (2019-2032)

Chapter 14. Canada Market

14.1. Overview
14.2. Economic Indicators
14.3. Demographics and Population Insights
14.4. Growth Drivers
14.5. Challenges and Barriers
14.6. Competitive Strategies
14.7. Emerging Players
14.8. Market Size and Forecast
- 14.8.1. Market Revenue, by Cancer Type (2019-2032)
- 14.8.2. Market Revenue, by Technology (2019-2032)
- 14.8.3. Market Revenue, by Sample Type (2019-2032)
- 14.8.4. Market Revenue, by Age Group (2019-2032)
- 14.8.5. Market Revenue, by Patient Type (2019-2032)
- 14.8.6. Market Revenue, by End User (2019-2032)

Chapter 15. Germany Market

15.1. Overview
15.2. Economic Indicators
15.3. Demographics and Population Insights
15.4. Growth Drivers
15.5. Challenges and Barriers
15.6. Competitive Strategies
15.7. Emerging Players
15.8. Market Size and Forecast
- 15.8.1. Market Revenue, by Cancer Type (2019-2032)
- 15.8.2. Market Revenue, by Technology (2019-2032)
- 15.8.3. Market Revenue, by Sample Type (2019-2032)
- 15.8.4. Market Revenue, by Age Group (2019-2032)
- 15.8.5. Market Revenue, by Patient Type (2019-2032)
- 15.8.6. Market Revenue, by End User (2019-2032)

Chapter 16. U.K. Market

16.1. Overview
16.2. Economic Indicators
16.3. Demographics and Population Insights
16.4. Growth Drivers
16.5. Challenges and Barriers
16.6. Competitive Strategies
16.7. Emerging Players
16.8. Market Size and Forecast
- 16.8.1. Market Revenue, by Cancer Type (2019-2032)
- 16.8.2. Market Revenue, by Technology (2019-2032)
- 16.8.3. Market Revenue, by Sample Type (2019-2032)
- 16.8.4. Market Revenue, by Age Group (2019-2032)
- 16.8.5. Market Revenue, by Patient Type (2019-2032)
- 16.8.6. Market Revenue, by End User (2019-2032)

Chapter 17. France Market

17.1. Overview
17.2. Economic Indicators
17.3. Demographics and Population Insights
17.4. Growth Drivers
17.5. Challenges and Barriers
17.6. Competitive Strategies
17.7. Emerging Players
17.8. Market Size and Forecast
- 17.8.1. Market Revenue, by Cancer Type (2019-2032)
- 17.8.2. Market Revenue, by Technology (2019-2032)
- 17.8.3. Market Revenue, by Sample Type (2019-2032)
- 17.8.4. Market Revenue, by Age Group (2019-2032)
- 17.8.5. Market Revenue, by Patient Type (2019-2032)
- 17.8.6. Market Revenue, by End User (2019-2032)

Chapter 18. Italy Market

18.1. Overview
18.2. Economic Indicators
18.3. Demographics and Population Insights
18.4. Growth Drivers
18.5. Challenges and Barriers
18.6. Competitive Strategies
18.7. Emerging Players
18.8. Market Size and Forecast
- 18.8.1. Market Revenue, by Cancer Type (2019-2032)
- 18.8.2. Market Revenue, by Technology (2019-2032)
- 18.8.3. Market Revenue, by Sample Type (2019-2032)
- 18.8.4. Market Revenue, by Age Group (2019-2032)
- 18.8.5. Market Revenue, by Patient Type (2019-2032)
- 18.8.6. Market Revenue, by End User (2019-2032)

Chapter 19. Spain Market

19.1. Overview
19.2. Economic Indicators
19.3. Demographics and Population Insights
19.4. Growth Drivers
19.5. Challenges and Barriers
19.6. Competitive Strategies
19.7. Emerging Players
19.8. Market Size and Forecast
- 19.8.1. Market Revenue, by Cancer Type (2019-2032)
- 19.8.2. Market Revenue, by Technology (2019-2032)
- 19.8.3. Market Revenue, by Sample Type (2019-2032)
- 19.8.4. Market Revenue, by Age Group (2019-2032)
- 19.8.5. Market Revenue, by Patient Type (2019-2032)
- 19.8.6. Market Revenue, by End User (2019-2032)

Chapter 20. Japan Market

20.1. Overview
20.2. Economic Indicators
20.3. Demographics and Population Insights
20.4. Growth Drivers
20.5. Challenges and Barriers
20.6. Competitive Strategies
20.7. Emerging Players
20.8. Market Size and Forecast
- 20.8.1. Market Revenue, by Cancer Type (2019-2032)
- 20.8.2. Market Revenue, by Technology (2019-2032)
- 20.8.3. Market Revenue, by Sample Type (2019-2032)
- 20.8.4. Market Revenue, by Age Group (2019-2032)
- 20.8.5. Market Revenue, by Patient Type (2019-2032)
- 20.8.6. Market Revenue, by End User (2019-2032)

Chapter 21. China Market

21.1. Overview
21.2. Economic Indicators
21.3. Demographics and Population Insights
21.4. Growth Drivers
21.5. Challenges and Barriers
21.6. Competitive Strategies
21.7. Emerging Players
21.8. Market Size and Forecast
- 21.8.1. Market Revenue, by Cancer Type (2019-2032)
- 21.8.2. Market Revenue, by Technology (2019-2032)
- 21.8.3. Market Revenue, by Sample Type (2019-2032)
- 21.8.4. Market Revenue, by Age Group (2019-2032)
- 21.8.5. Market Revenue, by Patient Type (2019-2032)
- 21.8.6. Market Revenue, by End User (2019-2032)

Chapter 22. India Market

22.1. Overview
22.2. Economic Indicators
22.3. Demographics and Population Insights
22.4. Growth Drivers
22.5. Challenges and Barriers
22.6. Competitive Strategies
22.7. Emerging Players
22.8. Market Size and Forecast
- 22.8.1. Market Revenue, by Cancer Type (2019-2032)
- 22.8.2. Market Revenue, by Technology (2019-2032)
- 22.8.3. Market Revenue, by Sample Type (2019-2032)
- 22.8.4. Market Revenue, by Age Group (2019-2032)
- 22.8.5. Market Revenue, by Patient Type (2019-2032)
- 22.8.6. Market Revenue, by End User (2019-2032)

Chapter 23. South Korea Market

23.1. Overview
23.2. Economic Indicators
23.3. Demographics and Population Insights
23.4. Growth Drivers
23.5. Challenges and Barriers
23.6. Competitive Strategies
23.7. Emerging Players
23.8. Market Size and Forecast
- 23.8.1. Market Revenue, by Cancer Type (2019-2032)
- 23.8.2. Market Revenue, by Technology (2019-2032)
- 23.8.3. Market Revenue, by Sample Type (2019-2032)
- 23.8.4. Market Revenue, by Age Group (2019-2032)
- 23.8.5. Market Revenue, by Patient Type (2019-2032)
- 23.8.6. Market Revenue, by End User (2019-2032)

Chapter 24. Australia Market

24.1. Overview
24.2. Economic Indicators
24.3. Demographics and Population Insights
24.4. Growth Drivers
24.5. Challenges and Barriers
24.6. Competitive Strategies
24.7. Emerging Players
24.8. Market Size and Forecast
- 24.8.1. Market Revenue, by Cancer Type (2019-2032)
- 24.8.2. Market Revenue, by Technology (2019-2032)
- 24.8.3. Market Revenue, by Sample Type (2019-2032)
- 24.8.4. Market Revenue, by Age Group (2019-2032)
- 24.8.5. Market Revenue, by Patient Type (2019-2032)
- 24.8.6. Market Revenue, by End User (2019-2032)

Chapter 25. Brazil Market

25.1. Overview
25.2. Economic Indicators
25.3. Demographics and Population Insights
25.4. Growth Drivers
25.5. Challenges and Barriers
25.6. Competitive Strategies
25.7. Emerging Players
25.8. Market Size and Forecast
- 25.8.1. Market Revenue, by Cancer Type (2019-2032)
- 25.8.2. Market Revenue, by Technology (2019-2032)
- 25.8.3. Market Revenue, by Sample Type (2019-2032)
- 25.8.4. Market Revenue, by Age Group (2019-2032)
- 25.8.5. Market Revenue, by Patient Type (2019-2032)
- 25.8.6. Market Revenue, by End User (2019-2032)

Chapter 26. Mexico Market

26.1. Overview
26.2. Economic Indicators
26.3. Demographics and Population Insights
26.4. Growth Drivers
26.5. Challenges and Barriers
26.6. Competitive Strategies
26.7. Emerging Players
26.8. Market Size and Forecast
- 26.8.1. Market Revenue, by Cancer Type (2019-2032)
- 26.8.2. Market Revenue, by Technology (2019-2032)
- 26.8.3. Market Revenue, by Sample Type (2019-2032)
- 26.8.4. Market Revenue, by Age Group (2019-2032)
- 26.8.5. Market Revenue, by Patient Type (2019-2032)
- 26.8.6. Market Revenue, by End User (2019-2032)

Chapter 27. Saudi Arabia Market

27.1. Overview
27.2. Economic Indicators
27.3. Demographics and Population Insights
27.4. Growth Drivers
27.5. Challenges and Barriers
27.6. Competitive Strategies
27.7. Emerging Players
27.8. Market Size and Forecast
- 27.8.1. Market Revenue, by Cancer Type (2019-2032)
- 27.8.2. Market Revenue, by Technology (2019-2032)
- 27.8.3. Market Revenue, by Sample Type (2019-2032)
- 27.8.4. Market Revenue, by Age Group (2019-2032)
- 27.8.5. Market Revenue, by Patient Type (2019-2032)
- 27.8.6. Market Revenue, by End User (2019-2032)

Chapter 28. South Africa Market

28.1. Overview
28.2. Economic Indicators
28.3. Demographics and Population Insights
28.4. Growth Drivers
28.5. Challenges and Barriers
28.6. Competitive Strategies
28.7. Emerging Players
28.8. Market Size and Forecast
- 28.8.1. Market Revenue, by Cancer Type (2019-2032)
- 28.8.2. Market Revenue, by Technology (2019-2032)
- 28.8.3. Market Revenue, by Sample Type (2019-2032)
- 28.8.4. Market Revenue, by Age Group (2019-2032)
- 28.8.5. Market Revenue, by Patient Type (2019-2032)
- 28.8.6. Market Revenue, by End User (2019-2032)

Chapter 29. U.A.E. Market

29.1. Overview
29.2. Economic Indicators
29.3. Demographics and Population Insights
29.4. Growth Drivers
29.5. Challenges and Barriers
29.6. Competitive Strategies
29.7. Emerging Players
29.8. Market Size and Forecast
- 29.8.1. Market Revenue, by Cancer Type (2019-2032)
- 29.8.2. Market Revenue, by Technology (2019-2032)
- 29.8.3. Market Revenue, by Sample Type (2019-2032)
- 29.8.4. Market Revenue, by Age Group (2019-2032)
- 29.8.5. Market Revenue, by Patient Type (2019-2032)
- 29.8.6. Market Revenue, by End User (2019-2032)

Chapter 30. Company Profiles

Chapter 31. Appendix

31.1. Sources and References
31.2. Related Reports

Lung Cancer Screening Market Size & Opportunities Analysis - Growth Strategies, Competitiveness, and Forecasts (2026 - 2032)